title: [Hungarian data on inflammatory bowel diseases: analytical data on ulcerative colistis].
abstract: Prospective data collection seems to be essential in evidence-based medicine. Because of the new therapeutic options, the need for standard data collection and testing has significantly increased. In Hungary, a registry for patients with inflammatory bowel disease has already been set up, which makes it possible for clinicians to collect prospective data on their patients.
  
  
  OBJECTIVE
  Basic characteristics of the database of patients with ulcerative colitis are presented in this paper.
  
  
  METHODS
  The inflammatory bowel disease registry uses the programme of Microsoft Access database management system. Data are stored in a central server.
  
  
  RESULTS
  The incidence of inflammatory bowel diseases has been permanently increasing in Hungary; however, its overall prevalence is still low among the European countries. The frequent administration of immunosuppressive medications (azathioprine and corticosteroids) and their increased doses worsen the estimation of the activity.
  
  
  CONCLUSIONS
  1., It would be very useful to gain prospective data from all national centres. This kind of database would be able to give a complete picture regarding the Hungarian therapeutical practice. 2., Medications of patients may alter the clinical value of the laboratory findings in the process of determining the severity of the disease.
authors.affiliation: Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika, Budapest. mihpal@yahoo.co.uk
authors.forename: Pál
authors.initials: P
authors.lastname: Miheller
authors.forename: Ferenc
authors.initials: F
authors.lastname: Nagy
authors.forename: Károly
authors.initials: K
authors.lastname: Palatka
authors.forename: István
authors.initials: I
authors.lastname: Altorjay
authors.forename: Gábor
authors.initials: G
authors.lastname: Horváth
authors.forename: Katalin
authors.initials: K
authors.lastname: Lőrinczy
authors.forename: László
authors.initials: L
authors.lastname: Újszászy
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Virányi
authors.forename: Attila
authors.initials: A
authors.lastname: Szepes
authors.forename: Tamás
authors.initials: T
authors.lastname: Molnár
authors.forename: Klaudia
authors.initials: K
authors.lastname: Farkas
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szepes
authors.forename: Tibor
authors.initials: T
authors.lastname: Nyári
authors.forename: Tibor
authors.initials: T
authors.lastname: Wittmann
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Tulassay
mesh_terms: D000328:Adult; D000368:Aged; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012008:Recurrence; D012042:Registries; D012720:Severity of Illness Index
chemical_list: D007166:Immunosuppressive Agents